Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.
Department of Infectious Diseases, University of Gothenburg, Sweden.
B A
BA
Claesson
R
R
Schneerson
J B
JB
Robbins
J
J
Johansson
T
T
Lagergard
J
J
Taranger
D
D
Bryla
L
L
Levi
T
T
Cramton
B
B
Trollfors
D000907:Antibodies, Bacterial / Q000096:biosynthesis*; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology*; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007223:Infant; D013745:Tetanus Toxoid / Q000009:adverse effects / Q000276:immunology*
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C055753:Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate; D013745:Tetanus Toxoid